Answer
The most frequently reported treatment-related adverse reaction in clinical studies involving 2,170 patients treated with DuoTrav was ocular hyperaemia, reported in 12.0%.
Sources for this answer
- DuoTrav eye drops solutionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 18Document updated
Sources checked